Protein phosphatase inhibitor calyculin-A modulates activation markers in TRAP-stimulated human platelets

Platelets. 2010;21(7):555-62. doi: 10.3109/09537104.2010.499156.

Abstract

Platelet activation is accompanied with the phosphorylation of a number of proteins on serine (Ser) and threonine (Thr) residues. The phosphorylation level of these proteins is dependent upon the protein kinase/phosphatase activity ratio. The aim of this study was to investigate the consequences of inhibiting protein phosphatase 1 (PP1) and 2A (PP2A) on platelet functions. Protein phosphatases were inhibited by preincubation of platelet rich plasma (PRP) samples with calyculin-A (CLA). Subsequently, platelets were activated by thrombin-receptor activating peptide (TRAP) and platelet aggregation, platelet-derived microparticle (PMP) formation, surface expressions of P-selectin (CD62), lysosome-associated membrane protein (CD63), glycoprotein Ib and IIb were examined. Phosphatase activity was determined by using phosphorylated 20 kDa myosin light chain (P-MLC20) as substrate. In CLA-treated platelets substantial decrease of P-MLC20 phosphatase activity was observed. CLA significantly suppressed TRAP-induced surface expression of P-selectin and CD63 in a concentration-dependent manner as compared to non-treated samples and moderately decreased platelet aggregation. In TRAP-activated samples, 50 nM of CLA pretreatment completely abolished the level of PMPs and the prevention of GPIb downregulation was also observed; however, no difference was found in GPIIb expression. In conclusion, PP1 and PP2A-catalyzed dephosphorylation processes have crucial roles in PMP formation and in the regulation of alpha-granule and lysosome secretion in human platelets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Platelets / drug effects*
  • Blood Platelets / enzymology
  • Blood Platelets / metabolism
  • Blood Platelets / physiology
  • Down-Regulation
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Marine Toxins
  • Oxazoles / pharmacology*
  • P-Selectin / antagonists & inhibitors
  • P-Selectin / biosynthesis
  • P-Selectin / blood
  • Peptide Fragments / pharmacology
  • Platelet Activation / drug effects*
  • Platelet Activation / physiology
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
  • Protein Phosphatase 1 / antagonists & inhibitors*
  • Protein Phosphatase 1 / blood
  • Protein Phosphatase 2 / antagonists & inhibitors*
  • Protein Phosphatase 2 / blood
  • Receptors, IgG / antagonists & inhibitors
  • Receptors, IgG / biosynthesis
  • Receptors, IgG / blood

Substances

  • Enzyme Inhibitors
  • FCGR1A protein, human
  • Marine Toxins
  • Oxazoles
  • P-Selectin
  • Peptide Fragments
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Receptors, IgG
  • thrombin receptor peptide SFLLRNP
  • calyculin A
  • Protein Phosphatase 1
  • Protein Phosphatase 2